IL-38 blockade induces anti-tumor immunity by abrogating tumor-mediated suppression of early immune activation.
Dowling JP, Nikitin PA, Shen F, Shukla H, Finn JP, Patel N, Swider C, Bingaman-Steele JL, Nicolescu C, Sikorski EL, Greenawalt EJ, Morin MJ, Robinson MK, Lundgren K, Harman BC.
Dowling JP, et al. Among authors: sikorski el.
MAbs. 2023 Jan-Dec;15(1):2212673. doi: 10.1080/19420862.2023.2212673.
MAbs. 2023.
PMID: 37216961
Free PMC article.